Take the data-collection burden off your staff by offering patients an easy risk assessment questionnaire in the waiting room that takes less than 5 minutes. CancerIQ's user-friendly screening tools allow you to replace long paper forms and quickly identify the 20% of your population eligible for counseling, testing or MRI.
Most genetic specialist spend 50% of their time on admin work, effectively reducing their appointment capacity. CancerIQ’s modern productivity tools streamline genetics appointments and reduce manual paperwork so providers can offer an enhanced patient experience.
Once patients have been identified as high-risk, CancerIQ helps you move beyond a manual spread sheet to track patient outcomes over time. Providers can utilize CancerIQ’s custom emails and education to keep patients engaged and improve long-term outcomes.
Yes. CancerIQ was built with the latest, most modern technology over the last three years. As a result, CancerIQ can communicate with any EMR system on the market. To get started and integrate with a new EMR vendor (or any other type of centralized technology), it helps if the customer makes the introduction.
We started this company by testing our software on various patient populations, including thousands of elderly patients. Our data indicates that 85% of patients can complete the questionnaire without staff assistance because we’ve been thoughtful about three features:
Yes, it’s fully web-based. The benefits to you is less IT resources. Additionally, Cancer IQ can always stay up to date. We use the NCCN guidelines to identify patients who are at risk and generate a library of clinical management recommendations. Given how often they change, we recommend our customers stay cloud-based so we can update the algorithms behind the scenes automatically.
The key to successfully engaging high risk patients throughout the care continuum is recognizing that each of your clinical areas and functions, each of your providers, and each care setting is different. Our system is built to flexibly address the needs of each. Over a third of our company is dedicated to supporting our clients and ensuring they’re successful. Your assigned CS team will work closely with you to understand current workflow, determine best practices and create an implementation plan complementary to your current systems/processes
Have more questions? Let us know:
Feyi received both her Bachelor’s and MBA from The Wharton School. Prior to CancerIQ, she worked as a management consultant, investor,
Haibo received his Bachelor’s in Economics and Psychology at Harvard University and his MBA from the University of Chicago Booth School of Business. Haibo started his career as a research analyst at AQR Capital Management.
Dr. Olopade is a medical oncologist and Founder of the Clinical Cancer Genetics Program at the University of Chicago Medicine.